231 related articles for article (PubMed ID: 24455744)
1. Revisiting the cutaneous impact of oral hormone replacement therapy.
Piérard GE; Humbert P; Berardesca E; Gaspard U; Hermanns-Lê T; Piérard-Franchimont C
Biomed Res Int; 2013; 2013():971760. PubMed ID: 24455744
[TBL] [Abstract][Full Text] [Related]
2. Skin climacteric aging and hormone replacement therapy.
Quatresooz P; Piérard-Franchimont C; Gaspard U; Piérard GE
J Cosmet Dermatol; 2006 Mar; 5(1):3-8. PubMed ID: 17173565
[TBL] [Abstract][Full Text] [Related]
3. [The skin and menopause].
Thirion L; Piérard-Franchimont C; Arrese JE; Quatresooz P; Gaspard U; Piérard GE
Rev Med Liege; 2006 Mar; 61(3):159-62. PubMed ID: 16681001
[TBL] [Abstract][Full Text] [Related]
4. Skin viscoelasticity during hormone replacement therapy for climacteric ageing.
Piérard GE; Hermanns-Lê T; Paquet P; Piérard-Franchimont C
Int J Cosmet Sci; 2014 Feb; 36(1):88-92. PubMed ID: 24152248
[TBL] [Abstract][Full Text] [Related]
5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and the skin.
Brincat MP
Maturitas; 2000 May; 35(2):107-17. PubMed ID: 10924836
[TBL] [Abstract][Full Text] [Related]
7. Endocrine aspects of menopause.
Vagenakis AG
Clin Rheumatol; 1989 Jun; 8 Suppl 2():48-51. PubMed ID: 2667871
[TBL] [Abstract][Full Text] [Related]
8. [The risks of avoiding hormone replacement therapy during menopause].
Blümel JE; Arteaga E
Rev Med Chil; 2017 Jun; 145(6):760-764. PubMed ID: 29171625
[No Abstract] [Full Text] [Related]
9. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
10. The physiology of the menopause.
Barbo DM
Med Clin North Am; 1987 Jan; 71(1):11-22. PubMed ID: 3543538
[TBL] [Abstract][Full Text] [Related]
11. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
[TBL] [Abstract][Full Text] [Related]
12. Hormonal effects on skin aging.
Phillips TJ; Demircay Z; Sahu M
Clin Geriatr Med; 2001 Nov; 17(4):661-72, vi. PubMed ID: 11535422
[TBL] [Abstract][Full Text] [Related]
13. The role of prolactin in the menopause.
Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
[TBL] [Abstract][Full Text] [Related]
14. Biology of estrogens in skin: implications for skin aging.
Verdier-Sévrain S; Bonté F; Gilchrest B
Exp Dermatol; 2006 Feb; 15(2):83-94. PubMed ID: 16433679
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin.
Hall G; Phillips TJ
J Am Acad Dermatol; 2005 Oct; 53(4):555-68; quiz 569-72. PubMed ID: 16198774
[TBL] [Abstract][Full Text] [Related]
16. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
17. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.
Morrison JH; Brinton RD; Schmidt PJ; Gore AC
J Neurosci; 2006 Oct; 26(41):10332-48. PubMed ID: 17035515
[No Abstract] [Full Text] [Related]
18. Norethindrone--a review of therapeutic applications.
Taitel HF; Kafrissen ME
Int J Fertil Menopausal Stud; 1995; 40(4):207-23. PubMed ID: 8520623
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic problems of the menopause.
Graham-Brown R
Clin Dermatol; 1997; 15(1):143-5. PubMed ID: 9034662
[No Abstract] [Full Text] [Related]
20. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
Whittington R; Faulds D
Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
